6 months ago
ALNY
AnalystsKeay NakaeKeay Nakae's Stock Forecasts
AnalystsKeay Nakae
Analyst Ranking
Top 1%
#42 out of 4174 analysts
Average Return
+49.98%
Win Rate
35%26 out of 75
Risk vs Reward
Poor
Good
Keay Nakae's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +5,554.71% | $0.22 | $12.61 | 2020-06-02 - 2021-02-09 | Strong Buy |
Carecloud IncCCLD | +104.17% | $2.40 | $4.90 | 2017-11-13 - 2018-11-14 | Strong Buy |
Dicerna Pharmaceuticals IncDRNA | +70.89% | $22.19 | $37.92 | 2021-08-09 - 2021-12-09 | Strong Buy |
Mesoblast LtdMESO | +67.64% | $16.10 | $5.21 | 2020-12-03 - 2021-12-03 | Strong Sell |
Arrowhead Pharmaceuticals IncARWR | +62.51% | $19.39 | $31.51 | 2018-09-05 - 2019-09-06 | Strong Buy |
Keay Nakae Analyst Color
Get additional color on Keay Nakae's coverage of popular stocks
6 months ago
BTTX
a year ago
BTTX
a year ago
ABUS
Keay Nakae's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Coya Therapeutics IncCOYA | 1 | Strong Buy | $9.00 | +127.85% | Initiates Coverage On | 13 days ago |
Gain Therapeutics IncGANX | 1 | Strong Buy | $4.00 | -1.96% | Initiates Coverage On | 2 months ago |
Silence Therapeutics PLCSLN | 2 | Strong Buy | $29.00 | +123.42% | Maintains | 3 months ago |
Evelo Biosciences IncEVLO | 3 | Hold | $2.50 | +174.73% | Downgrades | 3 months ago |
Pear Therapeutics IncPEAR | 4 | Strong Buy | $8.00 | +550.41% | Maintains | 3 months ago |
Better Therapeutics IncBTTX | 4 | Strong Buy | $14.00 | +993.75% | Maintains | 3 months ago |
Synlogic IncSYBX | 1 | Strong Buy | $7.00 | +695.45% | Maintains | 3 months ago |
Femasys IncFEMY | 3 | Strong Buy | $12.00 | +916.95% | Maintains | 3 months ago |
Biomx IncPHGE | 4 | Strong Buy | $2.00 | +418.13% | Maintains | 3 months ago |
Emergent Biosolutions IncEBS | 8 | Strong Buy | $55.00 | +301.75% | Maintains | 3 months ago |
Axcella Health IncAXLA | 4 | Strong Buy | $5.00 | +595.41% | Maintains | 3 months ago |
Neubase Therapeutics IncNBSE | 5 | Hold | N/A | N/A | Downgrades | 4 months ago |
Avidity Biosciences IncRNA | 2 | Strong Buy | $27.00 | +11.11% | Maintains | 4 months ago |
Omega Therapeutics IncOMGA | 1 | Strong Buy | $12.00 | +78.84% | Initiates Coverage On | 5 months ago |
Exicure IncXCUR | 3 | Hold | $2.00 | +41.84% | Maintains | 6 months ago |
Sonnet Biotherapeutics Holdings IncSONN | 4 | Strong Buy | $2.00 | +88.68% | Maintains | 6 months ago |
Proqr Therapeutics NvPRQR | 5 | Hold | N/A | N/A | Downgrades | 6 months ago |
Sab Biotherapeutics IncSABS | 4 | Strong Buy | $3.00 | +310.96% | Maintains | 6 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $250.00 | +11.54% | Maintains | 6 months ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $17.00 | +21.17% | Initiates Coverage On | 7 months ago |
4d Pharma PLCLBPS | 1 | Hold | N/A | N/A | Downgrades | 7 months ago |
Mesoblast LtdMESO | 3 | Strong Sell | $2.50 | -36.87% | Maintains | 8 months ago |
Kaleido Biosciences IncKLDO | 3 | Hold | $1.70 | +1,033.33% | Downgrades | 10 months ago |
Arbutus Biopharma CorpABUS | 2 | Strong Buy | $6.00 | +106.90% | Maintains | a year ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $38.25 | N/A | Downgrades | a year ago |
Forte Biosciences IncFBRX | 2 | Hold | $3.50 | N/A | Upgrades | a year ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $94.00 | N/A | Maintains | 2 years ago |
Seres Therapeutics IncMCRB | 1 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Ocugen IncOCGN | 2 | Hold | $13.00 | N/A | Downgrades | 2 years ago |
Oncocyte CorpOCX | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $7.00 | N/A | Maintains | 5 years ago |
Carecloud IncCCLD | 1 | Strong Buy | $2.75 | N/A | Maintains | 5 years ago |
Biocept IncBIOC | 1 | Strong Buy | $2.50 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.